Results of second-look resection after primary resection of T1 tumour of the urinary bladder

被引:28
作者
Jahnson, S [1 ]
Wiklund, F
Duchek, M
Mestad, O
Rintala, E
Hellsten, S
Malmström, PU
机构
[1] Linkoping Univ Hosp, Dept Urol, S-58185 Linkoping, Sweden
[2] No Univ Hosp, Ctr Oncol, Umea, Sweden
[3] No Univ Hosp, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden
[4] Cent Hosp Rogaland, Dept Urol, Surg Clin, Stavanger, Norway
[5] Cent Hosp Rogaland, Dept Urol, Clin Orthoped, Stavanger, Norway
[6] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland
[7] Malmo Univ Hosp, Dept Urol, Malmo, Sweden
[8] Univ Uppsala Hosp, Dept Urol, Akad Sjukhuset, S-75185 Uppsala, Sweden
来源
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 2005年 / 39卷 / 03期
关键词
bladder cancer; primary resection; second-look resection;
D O I
10.1080/00365590510007793-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective. To study residual tumours at second-look resection in patients resected 4-8 weeks earlier for T1 tumours of the urinary bladder. Material and methods. All patients randomized in the ongoing Nordic T1G2-G3 Bladder Sparing Study with monitored data available were included in the study. Data on residual tumours at second-look resection were compared to basic patient and tumour characteristics. Results. There were 72 patients (56%) without and 57 with residual exophytic tumours. In the former group, 20 patients (28%) had carcinoma in situ, compared to 19 (33%) in the latter group. Potentially dangerous tumours (either carcinoma in situ, T1 or Ta grade 3) were observed in 55 patients (43%). Multiple tumours at primary resection were more prone to residual tumour at second-look resection than single tumours. No other tumour or patient characteristics could predict the occurrence of a residual tumour. Conclusions. Residual tumours are frequently observed at second-look resection 4-8 weeks after primary resection of T1 tumours. The majority of residual tumours detected at this stage are potentially dangerous; therefore, early second-look resection followed by intravesical instillation therapy is mandatory in patients with T1 tumours of the urinary bladder.
引用
收藏
页码:206 / 210
页数:5
相关论文
共 14 条
[1]   Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer:: A formal meta-analysis of comparative studies on recurrence and toxicity [J].
Böhle, A ;
Jocham, D ;
Bock, PR .
JOURNAL OF UROLOGY, 2003, 169 (01) :90-95
[2]   Second resection and prognosis of primary high risk superficial bladder cancer: Is cystectomy often too early? [J].
Brauers, A ;
Buettner, R ;
Jakse, G .
JOURNAL OF UROLOGY, 2001, 165 (03) :808-810
[3]   Impact of a second transurethral resection on the staging of T1 bladder cancer [J].
Dalbagni, G ;
Herr, HW ;
Reuter, VE .
UROLOGY, 2002, 60 (05) :822-824
[4]   Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy [J].
Dutta, SC ;
Smith, JA ;
Shappell, SB ;
Coffey, CS ;
Chang, SS ;
Cookson, MS .
JOURNAL OF UROLOGY, 2001, 166 (02) :490-493
[5]   Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance [J].
Griffiths, TRL ;
Charlton, M ;
Neal, DE ;
Powell, PH .
JOURNAL OF UROLOGY, 2002, 167 (06) :2408-2412
[6]   Effect of routine repeat transurethral resection for superficial bladder cancer:: A long-term observational study [J].
Grimm, MO ;
Steinhoff, C ;
Simon, X ;
Spiegelhalder, P ;
Ackermann, R ;
Vögeli, TA .
JOURNAL OF UROLOGY, 2003, 170 (02) :433-437
[7]   The value of a second transurethral resection in evaluating patients with bladder tumors [J].
Herr, HW .
JOURNAL OF UROLOGY, 1999, 162 (01) :74-76
[8]   Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? [J].
Herr, HW ;
Sogani, PC .
JOURNAL OF UROLOGY, 2001, 166 (04) :1296-1299
[9]   The importance of the depth of invasion in stage T1 bladder carcinoma: A prospective cohort study [J].
Holmang, S ;
Hedelin, H ;
Anderstrom, C ;
Holmberg, E ;
Johansson, SL .
JOURNAL OF UROLOGY, 1997, 157 (03) :800-803
[10]   Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder:: A Nordic study [J].
Kaasinen, E ;
Wijkström, H ;
Malmström, PU ;
Hellsten, S ;
Duchek, M ;
Mestad, O ;
Rintala, E .
EUROPEAN UROLOGY, 2003, 43 (06) :637-645